Medically reviewed by Femi Aremu, PharmD Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat people with type 2 diabetes. The drugs, classified as GLP-1 agonists, ...

A daily GLP-1 inhibitor class injection, Victoza remains an important drug for Novo Nordisk and sales continue to grow despite increased competition. Eli Lilly’s Trulicity (dulaglutide ...

The FDA approved Hikma's first generic referencing Victoza (liraglutide injection ... The FDA approved the first generic in this class of medications last month with the approval of a generic ...

4,321 of those people used semaglutide, and 2,509 people used liraglutide, another drug in the same class of GLP-1s which is sold under the brand name Victoza. The analysis found that the "people ...

China represents an untapped market for GLP-1 class diabetes drugs, according to Novo Nordisk, which is predicting "good momentum" for its already-approved Victoza, and its successor semaglutide.